亿腾嘉和(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06998 亿腾嘉和

交易中 08-13 15:34:40

1.670

-0.040

-2.34%

最高1.710	最低1.650	成交量42.90万
今开1.710	昨收1.710	日振幅3.51%
总市值33.20亿	流通市值33.20亿	总股本19.88亿
成交额72.09万	换手率0.02%	流通股本19.88亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06998","market":"HK","secType":"STK","nameCN":"亿腾嘉和","latestPrice":1.67,"timestamp":1786606203764,"preClose":1.71,"halted":0,"volume":429000,"delay":0,"changeRate":-0.0233918128654971,"floatShares":1988000000,"shares":1988000000,"eps":0.27330032563066414,"marketStatus":"交易中","change":-0.04,"latestTime":"08-13 15:34:40","open":1.71,"high":1.71,"low":1.65,"amount":720855,"amplitude":0.035088,"askPrice":1.69,"askSize":21500,"bidPrice":1.67,"bidSize":29500,"shortable":3,"etf":0,"ttmEps":0.257018604103731,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1786608600000},"marketStatusCode":2,"adr":0,"listingDate":1602000000000,"exchange":"SEHK","adjPreClose":1.71,"openAndCloseTimeList":[[1786584600000,1786593600000],[1786597200000,1786608000000]],"volumeRatio":0.293218,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06998","defaultTab":"news","newsList":[{"id":"1117179561","title":"亿腾嘉和（06998）GB268在乳腺癌Ib/II期试验完成首例给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1117179561","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117179561?lang=zh_cn&edition=full","pubTime":"2026-08-06 22:30","pubTimestamp":1786026657,"startTime":"0","endTime":"0","summary":"2026年8月6日，亿腾嘉和医药集团有限公司发布自愿公告称，其PD-1/CTLA-4/VEGF三特异性抗体GB268在治疗局部晚期不可切除或转移性乳腺癌的Ib/II期临床试验，于2026年8月5日完成首例受试者给药。该研究包含三种治疗方案：GB268单药、GB268联合化疗的免疫方案，以及GB268联合抗体偶联药物的方案。主要研究终点为评估联合治疗的安全性与耐受性，包括剂量限制性毒性，并考察GB268单药及其多种联合方案在相应乳腺癌人群中的初步抗肿瘤活性。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657302406","title":"亿腾嘉和(06998)：GB268 Ib/II期临床试验完成首例受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2657302406","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657302406?lang=zh_cn&edition=full","pubTime":"2026-08-06 22:24","pubTimestamp":1786026254,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿腾嘉和 发布公告，本公司高度差异化创新的PD-1/CTLA-4/VEGF三特异性抗体GB268用于治疗局部晚期不可切除或转移性乳腺癌的Ib/II期临床试验于2026年8月5日成功完成首例受试者给药。该临床方案贯穿一线、后线全疗程阶段，为全方位拓展GB268应用范围迈出第一步，未来本公司亦计划在更多晚期实体瘤领域开展多项联合治疗临床研究。GB268单药I期临床数据计划于2026年第四季度在欧洲肿瘤内科学会公布。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477023.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PSYK","BK1583","MDTX","IBBQ","BMED","BK1574","06998","BK1161","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197524050","title":"亿腾嘉和更新7月股份变动月报表，股本总量保持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1197524050","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197524050?lang=zh_cn&edition=full","pubTime":"2026-08-06 16:51","pubTimestamp":1786006317,"startTime":"0","endTime":"0","summary":"亿腾嘉和于2026年8月6日披露截至2026年7月31日的股份变动月报表。报告显示，公司法定注册股本维持3,000,000,000股，每股面值0.00002美元，合计60,000美元。截至本月底，总股本仍为2,014,041,774股，未发生总体增减变动。在股权激励方面，报告披露了多项购股权及受限制股份单位计划的最新进展。其中，2019年及2020年分别通过股东大会决议案所采纳的首次公开发售前/后的购股权计划和2023年购股权计划，总体期权数量在本月内无新增发行。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114642203","title":"亿腾嘉和（06998）景助达再许可协议终止　已向关联方累计支付6,000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114642203","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114642203?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:45","pubTimestamp":1785941156,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司8月5日公告，因Syndax Pharmaceuticals, Inc.向亿腾景昂药业（香港）有限公司发出终止通知，2013年4月18日签订的原许可协议即时终止。受此影响，泰州亿腾景昂药业股份有限公司无法继续向苏州亿腾药品销售有限公司授予景助达的商业化权利，导致双方于2023年5月9日签订的《2023年再许可协议》及其项下持续关连交易停止履行。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116846228","title":"亿腾嘉和回购20万股股份，总额约36.38万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1116846228","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116846228?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:56","pubTimestamp":1785239809,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司于2026年7月28日公告披露，当日于香港联交所场内回购普通股合共200,000股，占回购前公司已发行股本约0.01%。本次回购每股价格介乎1.76港元至1.88港元，合计耗资约36.38万港元。回购后，公司已发行股本总数为2,014,041,774股，其中1,988,499,774股为已发行在外股份，库藏股数量增至25,542,000股。公司表示，本次交易已取得董事会正式授权并符合香港联交所上市规则及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和回购20万股股份，总额约36.38万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654001377","title":"亿腾嘉和(06998.HK)7月28日斥资36.38万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654001377","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654001377?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:45","pubTimestamp":1785239118,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06998","BK1574","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194797343","title":"亿腾嘉和回购74,000股，总额约13.99万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194797343","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194797343?lang=zh_cn&edition=full","pubTime":"2026-07-27 19:45","pubTimestamp":1785152756,"startTime":"0","endTime":"0","summary":"亿腾嘉和于2026年7月27日发布翌日披露报表称，公司于当日在香港联交所回购普通股74,000股，占2026年7月24日现有已发行股本约0.004%。本次回购价格区间介乎每股港币1.85元至1.92元，总耗资约13.99万港元。回购后，公司已发行股份数由1,988,773,774股降至1,988,699,774股，库藏股增至25,342,000股。公告显示，回购根据公司于2026年6月26日通过的购回授权进行，可购回股份总数为199,074,827股。截至本次回购，已在交易所及其他交易所累计购回股份约2,048,500股，占该授权通过当日全数已发行股本的约0.1%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和回购74,000股，总额约13.99万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654463012","title":"亿腾嘉和(06998)7月27日耗资约13.99万港元回购7.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654463012","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654463012?lang=zh_cn&edition=full","pubTime":"2026-07-27 19:42","pubTimestamp":1785152555,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿腾嘉和(06998)公布，2026年7月27日耗资约13.99万港元回购7.4万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1472722.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","06998","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654050636","title":"亿腾嘉和于7月24日斥资37.26万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654050636","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654050636?lang=zh_cn&edition=full","pubTime":"2026-07-26 09:37","pubTimestamp":1785029820,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　亿腾嘉和（06998）发布公告，于2026年7月24日，该公司斥资37.26万港元回购20万股股份，每股回购价1.83-1.88港元。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-07-26/doc-inikawyp0571961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK1583","06998","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191463962","title":"亿腾嘉和：7月24日回购20万股股份，涉资约37.26万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191463962","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191463962?lang=zh_cn&edition=full","pubTime":"2026-07-24 17:46","pubTimestamp":1784886374,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司于2026年7月24日公告，宣布在香港联交所场内回购普通股200,000股，约占当日公司现有已发行股本的0.01%。每股回购价介乎每股1.83港元至1.88港元，合计涉资约37.26万港元。公司购回授权于2026年6月26日获股东大会批准，可回购股票总数为199,074,827股，截至目前已合计回购1,974,500股，占授权通过当日已发行股本约0.1%。公司在公告中确认，前述回购事项已获得董事会正式授权，相关程序依照适用上市规则及相关法律规定进行。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和：7月24日回购20万股股份，涉资约37.26万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653744410","title":"亿腾嘉和(06998)7月23日斥资34.9万港元回购18.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653744410","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653744410?lang=zh_cn&edition=full","pubTime":"2026-07-23 19:16","pubTimestamp":1784805380,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿腾嘉和(06998)发布公告，于2026年7月23日斥资34.9万港元回购18.3万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471567.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06998","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191999131","title":"亿腾嘉和7月23日回购18.3万股股份，涉资约34.87万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191999131","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191999131?lang=zh_cn&edition=full","pubTime":"2026-07-23 19:15","pubTimestamp":1784805348,"startTime":"0","endTime":"0","summary":"亿腾嘉和于2026年7月23日公告显示，公司当日于香港联交所场内回购普通股183,000股，约占回购前已发行股本的0.009%。此次回购每股价格介乎1.89港元至1.94港元，合计耗资约34.87万港元。公司回购授权由股东于2026年6月26日通过，可回购股份总数为199,074,827股，至今已累计回购1,774,500股，占该授权通过当日已发行股份总数约0.09%。公司确认本次股份购回已获公司董事会正式批准，并已遵守上市规则及相关法律。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和7月23日回购18.3万股股份，涉资约34.87万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653754422","title":"亿腾嘉和(06998.HK)7月22日耗资约38.61万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653754422","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653754422?lang=zh_cn&edition=full","pubTime":"2026-07-22 19:02","pubTimestamp":1784718130,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","06998","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144414549","title":"亿腾嘉和回购20万股股份，总额约38.61万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144414549","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144414549?lang=zh_cn&edition=full","pubTime":"2026-07-22 19:00","pubTimestamp":1784718059,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司于2026年7月22日发布公告，披露已于香港联交所回购公司普通股20万股，占回购前已发行股本约0.01%。回购价格区间介乎每股港币1.90元至1.97元，合计耗资约38.61万港元。公司于2026年6月26日获股东大会通过股份回购授权，授权总数为199,074,827股，截至公告日已累计回购1,591,500股，约占授权通过当日公司已发行股本的0.08%。本次回购后，公司在30天内将不会进行或公布新的股份发行或库藏股出售、转让计划，除非获得香港联交所批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和回购20万股股份，总额约38.61万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162192013","title":"亿腾嘉和回购13.35万股股份，总额约25.62万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1162192013","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162192013?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:26","pubTimestamp":1784636760,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司于2026年7月21日发布翌日披露报表，宣布于同日回购133,500股普通股，用作库存股份。本次回购股份数量占回购前现有已发行股份总数的0.007%，最高回购价为每股港币1.95元，最低回购价为每股港币1.90元，合计涉资港币256,240元。本次回购完成后，公司已发行股份总数仍为2,014,041,774股，其中已发行股份变更为1,989,356,774股，库存股份数增至24,685,000股。公司在公告中确认已遵守香港联合交易所有限公司证券上市规则及其他适用法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和回购13.35万股股份，总额约25.62万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151279457","title":"亿腾嘉和：7月20日回购20.00万股，涉资约38.94万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1151279457","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151279457?lang=zh_cn&edition=full","pubTime":"2026-07-20 20:52","pubTimestamp":1784551953,"startTime":"0","endTime":"0","summary":"2026年7月20日，亿腾嘉和医药集团有限公司在香港联交所公布翌日披露报表，披露当日于场内回购普通股事宜。公告显示，公司于2026年7月20日合共回购约20.00万股普通股，占此前已发行股本约0.01%，回购价格介乎每股港币1.91元至1.97元，总耗资约38.94万港元。根据公告，股东大会于2026年6月26日通过回购授权，可回购的股份总数为199,074,827股，截至目前已回购1,258,000股，占授权通过当日已发行股本约0.06%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和：7月20日回购20.00万股，涉资约38.94万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652215164","title":"亿腾嘉和(06998)7月20日斥资38.94万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652215164","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652215164?lang=zh_cn&edition=full","pubTime":"2026-07-20 20:50","pubTimestamp":1784551858,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿腾嘉和(06998)发布公告，于2026年7月20日，该公司斥资38.94万港元回购20万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469999.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","06998","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171251529","title":"亿腾嘉和7月17日回购20万股股份，涉资约37.92万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171251529","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171251529?lang=zh_cn&edition=full","pubTime":"2026-07-17 20:01","pubTimestamp":1784289709,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司于2026年7月17日发布公告，披露当日在香港联交所场内回购了200,000股普通股，占回购前公司已发行股本约0.01%。本次回购的价格区间为每股港币1.85至2.03港元，合计支付约379,165港元，回购股份将以库存股份形式持有。公告显示，在本次回购完成后，公司已发行股份数量变动为1,989,690,274股，库存股份增加至24,351,500股，已发行股份总数维持2,014,041,774股。本次回购后，在暂止期内公司新股发行或库存股份再次出售、转让的终止日期为2026年8月16日。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和7月17日回购20万股股份，涉资约37.92万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652528839","title":"亿腾嘉和(06998)7月17日斥资37.92万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652528839","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652528839?lang=zh_cn&edition=full","pubTime":"2026-07-17 19:54","pubTimestamp":1784289299,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿腾嘉和(06998)发布公告，于2026年7月17日斥资37.92万港元回购20万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1161","06998","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651942837","title":"亿腾嘉和(06998)出售Candid全部股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2651942837","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651942837?lang=zh_cn&edition=full","pubTime":"2026-07-16 22:33","pubTimestamp":1784212383,"startTime":"0","endTime":"0","summary":"出售事项涉及本公司于Candid持有的全部股权。于2026年5月3日，UCB宣布签立合并协议，据此其将收购Candid。根据投票协议及合并协议，本公司持有的Candid股份将于合并完成后自动转换为收取现金代价的权利，而本公司在Candid董事会及所必需的Candid股东批准合并后，须根据投票协议履行合约义务投票赞成合并。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1468695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06998","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0179},{"period":"1month","weight":-0.0757},{"period":"3month","weight":-0.332},{"period":"6month","weight":-0.4375},{"period":"1year","weight":-0.5},{"period":"ytd","weight":-0.43}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0507},{"period":"3month","weight":-0.036},{"period":"6month","weight":-0.0424},{"period":"1year","weight":0.0188},{"period":"ytd","weight":-0.0074}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"亿腾嘉和医药集团有限公司（原名：嘉和生物药业（开曼）控股有限公司）是一家专注于生物制药业务的企业。该公司主营业务涵盖人用生物制药产品的研发、商业化及产业化。该公司产品管线包括来罗西利（GB491）、GB261、GB263T、英夫利西单抗（GB242）、Coprelotamab（GB221）、GB223、利妥昔单抗（GB241）等，涉及乳腺癌、肺癌、胃肠肿瘤及血液肿瘤等疾病领域。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.069875},{"month":2,"riseRate":0.5,"avgChangeRate":0.016786},{"month":3,"riseRate":0.5,"avgChangeRate":0.013026},{"month":4,"riseRate":0.5,"avgChangeRate":-0.068745},{"month":5,"riseRate":0.5,"avgChangeRate":-0.031387},{"month":6,"riseRate":0.5,"avgChangeRate":0.007707},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.07514},{"month":8,"riseRate":0.5,"avgChangeRate":0.084713},{"month":9,"riseRate":0.4,"avgChangeRate":-0.083466},{"month":10,"riseRate":0.4,"avgChangeRate":-0.052461},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.008673},{"month":12,"riseRate":0.666667,"avgChangeRate":0.044784}],"exchange":"SEHK","name":"亿腾嘉和","nameEN":"EDDING GENOR"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亿腾嘉和(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亿腾嘉和(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亿腾嘉和,06998,亿腾嘉和股票,亿腾嘉和股票老虎,亿腾嘉和股票老虎国际,亿腾嘉和行情,亿腾嘉和股票行情,亿腾嘉和股价,亿腾嘉和股市,亿腾嘉和股票价格,亿腾嘉和股票交易,亿腾嘉和股票购买,亿腾嘉和股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亿腾嘉和(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亿腾嘉和(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}